论文部分内容阅读
据《中华妇产科杂志》1999年10月34卷第10期报道 为了确定醋酸甲孕酮(DMPA)作为避孕针使用致闭经后是否会出现雌激素水平低落,以评价DMPA的安全性,四川生殖卫生学院朱明辉等医生,对44例使用DMPA后闭经时间中位数(M)为18个月的妇女,进行病史询问、妇科检查、血清雌二醇(E2)和促卵泡激素(FSH)测定及阴道细胞学检查。 结果表明,所有对象在闭经后均未出现类似围绝经期综合征的症状和生殖道萎缩;血清
According to the “Chinese Journal of Obstetrics and Gynecology” October 1999 Volume 34, No. 10 reported in order to determine the use of medroxyprogesterone acetate (DMPA) as a contraceptive use induced amenorrhea after low estrogen levels to evaluate the safety of DMPA, Sichuan Reproductive Health Institute Zhu Minghui and other doctors, 44 cases of DMPA after amenorrhea median time (M) of 18 months for medical history, gynecological examination, serum estradiol (E2) and follicle stimulating hormone (FSH) determination And vaginal cytology. The results showed that all subjects did not have symptoms of perimenopausal symptoms and genital atrophy after amenorrhea; serum